Annex Advisory Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$232K Sell
2,692
-1,016
-27% -$90.3K ﹤0.01% 356
2026
Q2
$335K Sell
3,708
-1,647
-31% -$138K 0.01% 291
2026
Q1
$429K Sell
5,355
-86
-2% -$7.09K 0.01% 267
2025
Q4
$464K Buy
5,441
+16
+0.3% +$1.31K 0.01% 253
2025
Q3
$422K Buy
5,425
+4
+0.1% +$313 0.01% 231
2025
Q2
$424K Sell
5,421
-90
-2% -$6.71K 0.01% 229
2025
Q1
$399K Buy
5,511
+90
+2% +$6.44K 0.01% 235
2024
Q4
$401K Buy
5,421
+1,221
+29% +$85.5K 0.01% 228
2024
Q3
$277K Hold
4,200
– – 0.01% 239
2024
Q2
$388K Hold
4,200
– – 0.01% 204
2024
Q1
$401K Sell
4,200
-42
-1% -$3.53K 0.01% 201
2023
Q4
$323K Sell
4,242
-116
-3% -$8.07K 0.01% 209
2023
Q3
$302K Buy
+4,358
New +$350K 0.02% 191

Other funds holding EW

Annex Advisory Services's EW Position: Q3 2026 in Review

Annex Advisory Services reduced its Edwards Lifesciences (EW) stake by 27% in Q3 2026, selling an estimated $90.3K and leaving 2,692 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

Annex Advisory Services first reported a position in EW in Q3 2023 and has held it in 13 quarters since. The position peaked at $464K in Q4 2025. 325 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Annex Advisory Services held 2,692 shares of Edwards Lifesciences worth $232K as of Q3 2026.
  • Annex Advisory Services sold 1,016 Edwards Lifesciences shares in Q3 2026, an estimated $90.3K.
  • Edwards Lifesciences made up ﹤0.01% of Annex Advisory Services's portfolio in Q3 2026, its #356 holding.
  • Annex Advisory Services first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 13 quarters since.
  • Annex Advisory Services's Edwards Lifesciences position peaked at $464K in Q4 2025.
  • 325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Annex Advisory Services's 13F filing for Q3 2026, filed 16 Oct 2026.